Drug Profile
Brentuximab vedotin companion diagnostic - Roche Tissue Diagnostics
Alternative Names: ADCETRIS companion diagnostic - Roche Tissue DiagnosticsLatest Information Update: 15 Dec 2023
Price :
$50
*
At a glance
- Originator Ventana Medical Systems
- Developer Roche Tissue Diagnostics; Seagen; Takeda Oncology
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cutaneous T-cell lymphoma; T-cell lymphoma